Thursday, March 10 2022   \  Published by Am Badar & Am Badar.

Exciting New Patents from Indonesia’s Leading Bio-Tech Company

The year 2022 has not been here long enough, but our country has started a new chapter in the journey of Intellectual Property (IP), including a series of cases of IP violations that began to appear in mid-February. 

However, in the midst of the many cases of Intellectual Property infringement, we do have one good news. An Indonesian bio-tech company produced new innovations with large-scale potential in the field of medicine and acquired two new patents for them.

The patent was registered by PT Natura Nuswantara Nirmala alias Nucleus Farma who discovered two inventions in the form of the process of making sea cucumber hydrolyzate (Stichopus Variegatus) as a raw material for pharmaceutical preparations with patent number P00201907575.

While the other invention is in the form of health supplements containing extracts of snakehead fish (Channa Striata), temulawak (Curcuma Xanthorrhiza), and Moringa (Moringa Oleifera). The supplement is produced in the form of a ready-to-drink liquid with patent number P00201908169. Read more

 

Ready to Get Started?

Contact Sales